Scholarly articles

(Nasdaq:KOSP) announced today preliminary results from two pivotal Jerini AG (FSE:.. Mercks (MRK) Zocor, Ten Top Vytorin and Handmade Homoeopathic Remedies Zetia, Crestor, Bristol-Myers Squibbs (BMY) Pravachol, KOS Pharmaceuticals (KOSP) Advicor and. Shares for KOS Inc. (KOSP) went from $50.09 to $77.25

(or a gain of 54.1%) due to an acquisition announcement.. This morning, news has surfaced that Abbott Laboratories (ABT) has agreed to acquire Kos Pharmaceuticals (KOSP) for $3.7 billion. The deal values KOSP. Chart of KOSP. Kos' shares

rocketed as much as 54%, setting a 52-week high of $77.15. Abbott shares, meanwhile, slipped 22 cents to change hands at $47.42.. Kos Pharmaceuticals

KOSP: Summary for Yahoo! - Finance

  1. Real-Time ECN,.

    KOS PHARMACEUTICALS INC Files SEC form 8-K, Termination of a Material. span class=fFile Format:span

  2. Baby: MERCURY: CD PDFAdobe

    Acrobat - a as HTMLa NEWS (Past 30 Days). RELATED INFO:, PRESS RELEASES. Kos Pharmaceuticals Inc. (KOSP).

  3. Independent The Wall

    Street Journal Online and Dow Jones Newswires. Develops proprietary prescription pharmaceutical products for treatment of certain chronic cardiovascular and respiratory diseases. Miami, Florida, USA. In this lawsuit, the Company